596 related articles for article (PubMed ID: 28976574)
21. A biological effect-guided optimization approach using beam distal-edge avoidance for intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Med Phys; 2020 Sep; 47(9):3816-3825. PubMed ID: 32557747
[TBL] [Abstract][Full Text] [Related]
22. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
[TBL] [Abstract][Full Text] [Related]
23. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
24. Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.
Unkelbach J; Botas P; Giantsoudi D; Gorissen BL; Paganetti H
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1097-1106. PubMed ID: 27869082
[TBL] [Abstract][Full Text] [Related]
25. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
[No Abstract] [Full Text] [Related]
26. A fast robust optimizer for intensity modulated proton therapy using GPU.
Xu Y; Chen J; Cao R; Liu H; Xu XG; Pei X
J Appl Clin Med Phys; 2020 Mar; 21(3):123-133. PubMed ID: 32141699
[TBL] [Abstract][Full Text] [Related]
27. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
29. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
[TBL] [Abstract][Full Text] [Related]
30. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
31. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
[TBL] [Abstract][Full Text] [Related]
32. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
[TBL] [Abstract][Full Text] [Related]
33. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
34. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
[TBL] [Abstract][Full Text] [Related]
35. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
36. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
[TBL] [Abstract][Full Text] [Related]
37. Automated proton treatment planning with robust optimization using constrained hierarchical optimization.
Taasti VT; Hong L; Deasy JO; Zarepisheh M
Med Phys; 2020 Jul; 47(7):2779-2790. PubMed ID: 32196679
[TBL] [Abstract][Full Text] [Related]
38. Variations in linear energy transfer within clinical proton therapy fields and the potential for biological treatment planning.
Grassberger C; Trofimov A; Lomax A; Paganetti H
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1559-66. PubMed ID: 21163588
[TBL] [Abstract][Full Text] [Related]
39. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
40. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]